Torthaí cuardaigh - Lionel Adès

Beachtaigh na torthaí
  1. 1
    How we treat lower-risk myelodysplastic syndromes

    How we treat lower-risk myelodysplastic syndromes de réir Pierre Fenaux, Lionel Adès

    Foilsithe / Cruthaithe 2013
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    How we manage adults with myelodysplastic syndrome

    How we manage adults with myelodysplastic syndrome de réir Pierre Fenaux, Uwe Platzbecker, Lionel Adès

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Autoimmune manifestations associated with myelodysplastic syndromes

    Autoimmune manifestations associated with myelodysplastic syndromes de réir Éric Grignano, Vincent Jachiet, Pierre Fenaux, Lionel Adès, O. Fain, A. Mékinian

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Pericapillary hemorrhage as criterion of severe human digestive graft-versus-host disease

    Pericapillary hemorrhage as criterion of severe human digestive graft-versus-host disease de réir Marjan Ertault-Daneshpouy, Christophe Lebœuf, Marc Lémann, Fatiha Bouhidel, Lionel Adès, Éliane Gluckman, Gèrard Socié, Anne Janin

    Foilsithe / Cruthaithe 2004
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    ATM mediates constitutive NF-κB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia

    ATM mediates constitutive NF-κB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia de réir Jennifer Grosjean-Raillard, Maximilien Tailler, Lionel Adès, Jean‐Luc Perfettini, Claire Fabre, Thomas Braun, Stéphane de Botton, Pierre Fenaux, Guido Kroemer

    Foilsithe / Cruthaithe 2008
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Long-term outcome after bone marrow transplantation for severe aplastic anemia

    Long-term outcome after bone marrow transplantation for severe aplastic anemia de réir Lionel Adès, Jean‐Yves Mary, Marie Robin, C Ferry, Raphaël Porcher, Hélène Esperou, Patricia Ribaud, Agnès Devergie, R Traineau, Éliane Gluckman, Gèrard Socié

    Foilsithe / Cruthaithe 2003
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    The graft-versus-leukemia effect is mainly restricted to NIH-defined chronic graft-versus-host disease after reduced intensity conditioning before allogeneic stem cell transplantation

    The graft-versus-leukemia effect is mainly restricted to NIH-defined chronic graft-versus-host disease after reduced intensity conditioning before allogeneic stem cell transplantat... de réir Sylvain Thépot, Jing Zhou, Aurore Perrot, Marie Robin, Aliénor Xhaard, Régis Peffault de Latour, Lionel Adès, Patricia Ribaud, Anna D. Petropoulou, Raphaël Porcher, Gèrard Socié

    Foilsithe / Cruthaithe 2010
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    Erlotinib exhibits antineoplastic off-target effects in AML and MDS: a preclinical study

    Erlotinib exhibits antineoplastic off-target effects in AML and MDS: a preclinical study de réir Simone Boehrer, Lionel Adès, Thorsten Braun, Lorenzo Galluzzi, J. Grosjean, Claire Fabre, Geneviève Roux, Claude Gardin, Antoine Martin, Stéphane de Botton, Pierre Fenaux, Guido Kroemer

    Foilsithe / Cruthaithe 2007
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    Prognostic value of apoptotic cells and infiltrating neutrophils in graft-versus-host disease of the gastrointestinal tract in humans: TNF and Fas expression

    Prognostic value of apoptotic cells and infiltrating neutrophils in graft-versus-host disease of the gastrointestinal tract in humans: TNF and Fas expression de réir Gèrard Socié, Jean‐Yves Mary, Marc Lémann, Marjan Daneshpouy, Philippe Guardiola, Véronique Meignin, Lionel Adès, Hélène Esperou, Patricia Ribaud, Agnès Devergie, Éliane Gluckman, Jean‐Claude Ameisen, Anne Janin

    Foilsithe / Cruthaithe 2003
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    Long-term outcome of hepatitis C infection after bone marrow transplantation

    Long-term outcome of hepatitis C infection after bone marrow transplantation de réir Régis Peffault de Latour, Vincent Lévy, Tarik Asselah, Patrick Marcellin, Catherine Scieux, Lionel Adès, R Traineau, Agnès Devergie, Patricia Ribaud, Hélène Esperou, Éliane Gluckman, Dominique Valla, Gèrard Socié

    Foilsithe / Cruthaithe 2003
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    Very long-term remission with azacitidine in VEXAS syndrome

    Very long-term remission with azacitidine in VEXAS syndrome de réir Lin‐Pierre Zhao, Vincent Jachiet, Olivier Kosmider, Lise Larcher, Emmanuelle Clappier, Marie Sébert, Lionel Adès, Pierre Hirsch, T. Mahévas, Maxime Battistella, Jean‐David Bouaziz, A. Mékinian, Pierre Fenaux, MINHEMON FRENVEX

    Foilsithe / Cruthaithe 2025
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    Dual origin of relapses in retinoic-acid resistant acute promyelocytic leukemia

    Dual origin of relapses in retinoic-acid resistant acute promyelocytic leukemia de réir Jacqueline Lehmann‐Che, Cécile Bally, Éric Letouzé, Caroline Berthier, Hao Yuan, Florence Jollivet, Lionel Adès, Bruno Cassinat, Pierre Hirsch, Arnaud Pigneux, Julien Mozziconacci, Scott C. Kogan, Pierre Fenaux, Hugues de Thé

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  13. 13
    Outcome of High-Risk Myelodysplastic Syndrome After Azacitidine Treatment Failure

    Outcome of High-Risk Myelodysplastic Syndrome After Azacitidine Treatment Failure de réir Thomas Prébet, Steven D. Gore, Benjamin Esterni, Claude Gardin, Raphaël Itzykson, Sylvain Thépot, François Dreyfus, Odile Beyne Rauzy, Christian Récher, Lionel Adès, Bruno Quesnel, C.L. Beach, Pierre Fenaux, Norbert Vey

    Foilsithe / Cruthaithe 2011
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  14. 14
    Allogeneic Hematopoietic Cell Transplantation in Patients Age 60-70 Years with De Novo High-Risk Myelodysplastic Syndrome or Secondary Acute Myelogenous Leukemia: Comparison with Patients Lacking Donors Who Received Azacitidine

    Allogeneic Hematopoietic Cell Transplantation in Patients Age 60-70 Years with De Novo High-Risk Myelodysplastic Syndrome or Secondary Acute Myelogenous Leukemia: Comparison with P... de réir Uwe Platzbecker, Johannes Schetelig, Jürgen Finke, Rudolf Trenschel, Bart L. Scott, Guido Kobbe, Kerstin Schaefer‐Eckart, Martin Bornhäuser, Raphaël Itzykson, Ulrich Germing, Dietrich W. Beelen, Gerhard Ehninger, Pierre Fenaux, H. Joachim Deeg, Lionel Adès

    Foilsithe / Cruthaithe 2012
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  15. 15
    Retinoic acid and arsenic trioxide trigger degradation of mutated NPM1, resulting in apoptosis of AML cells

    Retinoic acid and arsenic trioxide trigger degradation of mutated NPM1, resulting in apoptosis of AML cells de réir Hiba El Hajj, Zeina Dassouki, Caroline Berthier, Emmanuel Raffoux, Lionel Adès, Olivier Legrand, Rita Hleihel, Umut Şahin, Nadim Tawil, Ala Salameh, Kazem Zibara, Nadine Darwiche, Mohamad Mohty, Hervé Dombret, Pierre Fenaux, Hugues de Thé, Ali Bazarbachi

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  16. 16
    The revised IPSS is a powerful tool to evaluate the outcome of MDS patients treated with azacitidine: the GFM experience

    The revised IPSS is a powerful tool to evaluate the outcome of MDS patients treated with azacitidine: the GFM experience de réir Mathilde Lamarque, Sophie Raynaud, Raphaël Itzykson, Sylvain Thépot, Bruno Quesnel, François Dreyfus, Odile Beyne Rauzy, Pascal Turlure, Norbert Vey, Christian Récher, Caroline Dartigeas, Laurence Legros, Jacques Delaunay, Sorin Visanica, Aspasia Stamatoullas, Pierre Fenaux, Lionel Adès

    Foilsithe / Cruthaithe 2012
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  17. 17
    Synergistic effects of PRIMA-1<sup>Met</sup> (APR-246) and 5-azacitidine in <i>TP53</i>-mutated myelodysplastic syndromes and acute myeloid leukemia

    Synergistic effects of PRIMA-1<sup>Met</sup> (APR-246) and 5-azacitidine in <i>TP53</i>-mutated myelodysplastic syndromes and acute myeloid leukemia de réir Nabih Maslah, Norman Salomao, Louis Drevon, Emmanuelle Verger, Nicolas Partouche, Pierre Ly, Philippe Aubin, Nadia Naoui, Marie‐Hélène Schlageter, Cécile Bally, Elsa Miekoutima, Ramy Rahmé, Jacqueline Lehmann‐Che, Lionel Adès, Pierre Fenaux, Bruno Cassinat, Stéphane Giraudier

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  18. 18
    Efficacy and safety of lenalidomide in intermediate-2 or high-risk myelodysplastic syndromes with 5q deletion: results of a phase 2 study

    Efficacy and safety of lenalidomide in intermediate-2 or high-risk myelodysplastic syndromes with 5q deletion: results of a phase 2 study de réir Lionel Adès, Simone Boehrer, Thomas Prébet, Odile Beyne‐Rauzy, Laurence Legros, Christophe Ravoet, François Dreyfus, Aspasia Stamatoullas, Marie Pierre Chaury, Jacques Delaunay, Laurent Guy, Norbert Vey, Sara Burcheri, Rose-Marie Mbida, Natacha Hoarau, Claude Gardin, Pierre Fenaux

    Foilsithe / Cruthaithe 2008
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  19. 19
    Epstein-barr virus (EBV) reactivation in allogeneic stem-cell transplantation: relationship between viral load, EBV-specific T-cell reconstitution and rituximab therapy

    Epstein-barr virus (EBV) reactivation in allogeneic stem-cell transplantation: relationship between viral load, EBV-specific T-cell reconstitution and rituximab therapy de réir Emmanuel Clave, F. Agbalika, Véronique Bajzik, Régis Peffault de Latour, Mélanie Trillard, Claire Rabian, Catherine Scieux, Agnès Devergie, Gèrard Socié, Patricia Ribaud, Lionel Adès, C Ferry, Éliane Gluckman, Dominique Charron, Hélène Esperou, Antoine Toubert, Hélène Moins‐Teisserenc

    Foilsithe / Cruthaithe 2004
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  20. 20
    Clonal architecture of chronic myelomonocytic leukemias

    Clonal architecture of chronic myelomonocytic leukemias de réir Raphaël Itzykson, Olivier Kosmider, Aline Renneville, Margot Morabito, Claude Preudhomme, Céline Berthon, Lionel Adès, Pierre Fenaux, Uwe Platzbecker, Olivier Gagey, Philippe Rameau, Guillaume Meurice, Cédric Oréar, François Delhommeau, Olivier Bernard, Michaëla Fontenay, William Vainchenker, Nathalie Droin, Éric Solary

    Foilsithe / Cruthaithe 2013
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: